This page will host Events plug-in for all Clarion and trade events.

Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vivos Therapeutics, Inc. - Common Stock (NQ:VVOS)

0.8850 +0.0219 (+2.54%)
Streaming Delayed Price Updated: 9:57 AM EDT, Apr 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vivos Therapeutics, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Micron News: Why Is MU Stock Up Today? ↗
Micron (MU) stock is on the move Wednesday as one analyst believes the memory market will start to recover in the second half of 2023. 
Via InvestorPlace
News headline image
6 Things to Know About Atlis Motor Vehicles as AMV Stock Surges Today ↗
Atlis Motor Vehicles (AMV) stock is on the move Wednesday despite a lack of news from the electric vehicle (EV) company. 
Via InvestorPlace
News headline image
Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive... 
Via Benzinga
News headline image
The Sleep Apnea News That Has VVOS Stock Soaring Today ↗
Vivos Therapeutics (VVOS) stock is rocketing higher on Wednesday as investors react to positive news about its sleep apnea treatment. 
Via InvestorPlace
News headline image
Nasdaq Rises Over 100 Points; Crude Oil Drops Sharply ↗
U.S. stocks extended gains midway through trading, with the Dow Jones gaining around 250 points on Wednesday ahead of the release of minutes from the Fed's meeting. 
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces FDA Clearance of Proprietary Oral Appliance for Obstructive Sleep Apnea Treatment
Via Investor Brand Network
News headline image
Why Vivos Therapeutics (VVOS) Shares Are Skyrocketing Wednesday ↗
Vivos Therapeutics Inc (NASDAQ: VVOS) shares are trading higher by 85.14% to after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive... 
Via Benzinga
News headline image
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group. 
Via Benzinga
News headline image
Vaxart And 3 Other Stocks Under $1 Insiders Are Aggressively Buying ↗
The Dow Jones settled lower by over 350 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q2, Q3 Financial Report, Operational Update
Via Investor Brand Network
Topics Regulatory Compliance
News headline image
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical... 
Via Benzinga
News headline image
Earnings Scheduled For December 20, 2022 ↗
Companies Reporting Before The Bell • Treasure Global (NASDAQ:TGL) is likely to report earnings for its first quarter. 
Via Benzinga
News headline image
Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who... 
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Reports on Q2 Q3 2022 Financial Results, Announces Conference Call
Via Investor Brand Network
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 241 companies hit new 52-week lows. 
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Creates Strategic Medical Billing Partnership, New Revenue Stream
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Receives NASDAQ Notification Regarding Q3 Quarterly Report Filing
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Update on Revenue Recognition Review
Via Investor Brand Network
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 1076 companies hit new 52-week lows. 
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Q2 Earnings Delay
Via Investor Brand Network
Vivos Announces 4th Annual Breathing Wellness Conference in Cancún, Mexico, With Full Slate of World-Renowned Speakers
Vivos Therapeutics, Inc. (NASDAQ: VVOS) ("Vivos") is excited to announce the fourth annual Breathing Wellness Conference, which will take place Oct. 26-29, 2022, at the Hilton Hotel in Cancún, Mexico.... 
Via Newswire.com
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Reschedule Release of Q2 2022 Financial Results
Via Investor Brand Network
News headline image
Earnings Scheduled For August 15, 2022 ↗
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Q2 2022 Call to Discuss Financial Results
Via Investor Brand Network
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 92 companies set new 52-week lows. 
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Receives Regulatory Clearances in Australia for Line of Oral Appliances
Via Investor Brand Network
News headline image
Vivos Therapeutics Announces Multiple Regulatory Clearances in Australia for Its Entire Line of Oral Appliances
From Vivos Therapeutics, Inc.
Via Business Wire
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Presents Sleep Apnea Study Results at Annual SLEEP 2022 Event
Via Investor Brand Network
News headline image
91 Biggest Movers From Friday ↗
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto. 
Via Benzinga
News headline image
70 Biggest Movers From Friday ↗
Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.